ABLATUS THERAPEUTICS LIMITED

09812865 · Liquidation · Ltd · 10 yrs · Leeds

Express interest

Free account required · takes 10 seconds

What Chris sees

Live insights

Filing calendar

Companies House

Chris, your AI Deal Adviser

Annual accounts are overdue by 672 days (deadline was 30 Sept 2024). Their confirmation statement is overdue (was due 20 Oct 2024).

Next accounts

30 Sept 2024

Next confirmation

20 Oct 2024

Estimated valuation

Reading filed accounts…

Open full valuation calculator

Financial story

Reading accounts…

Assets: Not reported
Cash: Not reported
Net worth: Not reported
Liabilities: Not reported
Turnover: Not reported

Explore

Tap to expand

BLACKWOOD, Anne Dunlop, Dr

FLATHER, Marcus Denis, Professor

HAYES, Natalie Jayne, Dr

LOOI, Chung Yen, Dr

ALLAN, William David, Dr

Director · Resigned 2021-12-31

BROOKS, David Graham, Dr

Director · Resigned 2020-06-30

Keep exploring

Where next?

Similar companies→Group structure→

Express interest

Back to research

Companies House dossier

ABLATUS THERAPEUTICS LIMITED

09812865Liquidation· Ltd· England Wales· 2015-10-07Incorporated 2015-10-07Health 0/100 · Risk

Free account required · takes 10 seconds

Express Interest

Chris, your AI Deal Adviser

Chris · First read

ABLATUS THERAPEUTICS LIMITED is a Ltd currently liquidation, incorporated on 2015-10-07. There are 4 active officer(s) on record. 1 charge(s) registered, 1 satisfied. 0 active PSC(s) declared. Insolvency history is on file. Next accounts are due by 2024-09-30.

Group structure

Resolving PSC chain…

Built from the Companies House PSC bulk snapshot: we walk up to the ultimate parent, then walk down to every subsidiary that declares one of the nodes above as a corporate PSC. Foreign parents show as leaf nodes.